Abstract:A catalytic (5+1) cycloaddition of diazooxindoles with imidazolidines is described, providing a general and efficient synthetic route to medicinally attractive piperazine-spirooxindole frameworks in moderate to excellent yields under rhodium or copper catalysis. Moreover, diverse transformations of the obtained products have been achieved to access more complex and even drug-derived spirooxindoles. Importantly, the asymmetric version has also been realized by employing the combination of Cu(OTf)2 and a newly synthesized SaBOX ligand (L5), leading to optically active products with up to 93:7 e.r.. This report shows that rhodium and copper are complementary catalysts for this reaction, and that copper is more competent than rhodium in catalytic asymmetric reactions involving diazocarbene-ylide intermediates.
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to develop an efficient and general - purpose method for synthesizing piperazine - spiroindole skeleton compounds with pharmaceutical value. Specifically, through catalyzing the (5 + 1) cycloaddition reaction, the authors used diazaindole and imidazolidine as reactants and, under the action of rhodium or copper catalysts, successfully synthesized a variety of piperazine - spiroindole compounds and achieved moderate to excellent yields. In addition, the authors also successfully achieved the asymmetric version of the reaction. By using Cu(OTf)\(_2\) and the newly synthesized SaBOX ligand (L5), optically active products were obtained, with the highest enantiomeric ratio reaching 93:7.
### Key problems and solutions
1. **General - purpose and efficient synthesis method**:
- **Problem**: Currently, there is a lack of effective synthesis methods for preparing piperazine - spiroindole skeleton compounds, which have potential application values in drug development.
- **Solution**: The authors developed a catalytic (5 + 1) cycloaddition reaction. Using diazaindole and imidazolidine as reactants and through rhodium or copper catalysts, the target compounds were efficiently synthesized.
2. **Asymmetric synthesis**:
- **Problem**: How to achieve enantioselective synthesis to obtain optically active piperazine - spiroindole compounds?
- **Solution**: By optimizing the reaction conditions, especially by using Cu(OTf)\(_2\) and the newly synthesized SaBOX ligand (L5), the authors successfully achieved the asymmetric version of the reaction and obtained products with high enantioselectivity.
### Main contributions
- **Generality**: This method is applicable to a variety of diazaindole and imidazolidine substrates and has wide substrate applicability.
- **Efficiency**: Under optimized conditions, the reaction can generate the target products with moderate to excellent yields.
- **Asymmetric synthesis**: High enantioselective synthesis has been achieved, providing new possibilities for drug development.
### Potential applications
- **Drug development**: Piperazine - spiroindole skeleton compounds have broad application prospects in drug development, especially in the fields of anti - tumor, anti - virus and anti - inflammation.
- **Synthetic chemistry**: This method provides a new tool for synthetic chemists to construct complex organic molecules.
In conclusion, this paper has solved the problem of synthesizing piperazine - spiroindole skeleton compounds by developing an efficient catalytic (5 + 1) cycloaddition reaction and has successfully achieved asymmetric synthesis, providing important technical means for drug development and synthetic chemistry.